Joseph Khabbaza, MD
Pulmonary Disease · Akron, OHNPI 1760645428
Payments from drug & device makers
Across 1,221 payments — averaging $536.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$341K
- Regeneron Healthcare Solutions, Inc.$151K
- Sanofi$126K
- Baxter Healthcare$15K
- Tactile Systems Technology Inc$13K
- AstraZeneca$5K
- plus $3K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insmed, Inc. | 714 | $340,850 |
| Regeneron Healthcare Solutions, Inc. | 183 | $150,980 |
| Sanofi | 134 | $126,439 |
| Baxter Healthcare | 33 | $15,231 |
| Tactile Systems Technology Inc | 10 | $13,272 |
| AstraZeneca | 27 | $5,290 |
| Hill-rom Company, Inc | 1 | $875 |
| GSK | 34 | $616 |
| United Therapeutics Corporation | 15 | $343 |
| Teva Pharmaceuticals USA, Inc. | 16 | $246 |
| Verona Pharma, Inc. | 9 | $202 |
| Electromed, Inc. | 6 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $172 |
| Mylan Specialty L.p. | 5 | $139 |
| Amgen | 3 | $60 |
| Sanofi-aventis U.S. LLC | 1 | $57 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| Advanced Respiratory, Inc | 3 | $51 |
| Lilly USA, LLC | 3 | $47 |
| Merck | 2 | $40 |
| Averitas Pharma Inc. | 2 | $39 |
| Relievant Medsystems, Inc. | 2 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| EMD Serono, Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| GRT US Holding, Inc. | 1 | $20 |
| Viatris Specialty LLC | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Z-medica, LLC | 1 | $15 |
| Pfizer | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
How this compares
$655,372 in reported general payments places this provider in the 95th percentile of 571 pulmonary disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Akron
- Mohammad KhanAkron$388K
- Anthony CucciAkron$264K
- Bruce CorserCincinnati$8.2M
- Edward CordascoColumbus$8M
- Kristin HighlandCleveland$3.2M
- Brian ZenoColumbus$2.9M
- Jean ElwingCincinnati$2.4M
- Roy St JohnColumbus$1.9M
- Nishant GuptaCincinnati$1.5M
- Robert BaughmanCincinnati$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.